At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job. "I was in a really dark place," said ...
The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds. That's compared to ...
In McKenzie’s case, Jack prescribed the weight-loss drug Wegovy, which in late 2022 was approved for use in U.S. children over age 12. More than 6,000 kids in that age group received Wegovy in ...
At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job. “I was in a really dark place ...
New research shows the number of 12- to 25-year-olds who used diabetes and obesity drugs such as Wegovy and Ozempic climbed from about 8,700 a month in 2020 to 60,000 a month in 2023. Overall, in ...